[1-[2-(cyclopropylamino)pyrido[3,4-b]pyrazin-3-yl]piperidin-4-yl]-(3-methoxyazetidin-1-yl)methanone;N-cyclopropyl-3-[4-[(2,5-difluorophenyl)-fluoromethyl]piperidin-1-yl]-7-methylpyrido[3,4-b]pyrazin-2-amine

C43H50F3N11O2 — CID 118308605

IUPAC[1-[2-(cyclopropylamino)pyrido[3,4-b]pyrazin-3-yl]piperidin-4-yl]-(3-methoxyazetidin-1-yl)methanone;N-cyclopropyl-3-[4-[(2,5-difluorophenyl)-fluoromethyl]piperidin-1-yl]-7-methylpyrido[3,4-b]pyrazin-2-amine
SMILESCOC1CN(C(=O)C2CCN(c3nc4cnccc4nc3NC3CC3)CC2)C1.Cc1cc2nc(NC3CC3)c(N3CCC(C(F)c4cc(F)ccc4F)CC3)nc2cn1
InChIInChI=1S/C23H24F3N5.C20H26N6O2/c1-13-10-19-20(12-27-13)30-23(22(29-19)28-16-3-4-16)31-8-6-14(7-9-31)21(26)17-11-15(24)2-5-18(17)25;1-28-15-11-26(12-15)20(27)13-5-8-25(9-6-13)19-18(22-14-2-3-14)23-16-4-7-21-10-17(16)24-19/h2,5,10-12,14,16,21H,3-4,6-9H2,1H3,(H,28,29);4,7,10,13-15H,2-3,5-6,8-9,11-12H2,1H3,(H,22,23)
InChIKeyLIRDQRQZDXWXAZ-UHFFFAOYSA-N
MW809.94 g/mol
LogP6.79
Rot. Bonds10

About [1-[2-(cyclopropylamino)pyrido[3,4-b]pyrazin-3-yl]piperidin-4-yl]-(3-methoxyazetidin-1-yl)methanone;N-cyclopropyl-3-[4-[(2,5-difluorophenyl)-fluoromethyl]piperidin-1-yl]-7-methylpyrido[3,4-b]pyrazin-2-amine

[1-[2-(cyclopropylamino)pyrido[3,4-b]pyrazin-3-yl]piperidin-4-yl]-(3-methoxyazetidin-1-yl)methanone;N-cyclopropyl-3-[4-[(2,5-difluorophenyl)-fluoromethyl]piperidin-1-yl]-7-methylpyrido[3,4-b]pyrazin-2-amine (PubChem CID 118308605) has the molecular formula C43H50F3N11O2 and a molecular weight of 809.94 g/mol. Its IUPAC name is [1-[2-(cyclopropylamino)pyrido[3,4-b]pyrazin-3-yl]piperidin-4-yl]-(3-methoxyazetidin-1-yl)methanone;N-cyclopropyl-3-[4-[(2,5-difluorophenyl)-fluoromethyl]piperidin-1-yl]-7-methylpyrido[3,4-b]pyrazin-2-amine.

Molecular Properties

Compound Name[1-[2-(cyclopropylamino)pyrido[3,4-b]pyrazin-3-yl]piperidin-4-yl]-(3-methoxyazetidin-1-yl)methanone;N-cyclopropyl-3-[4-[(2,5-difluorophenyl)-fluoromethyl]piperidin-1-yl]-7-methylpyrido[3,4-b]pyrazin-2-amine
PubChem CID118308605
Molecular FormulaC43H50F3N11O2
Molecular Weight809.94 g/mol
Exact Mass809.41
IUPAC Name[1-[2-(cyclopropylamino)pyrido[3,4-b]pyrazin-3-yl]piperidin-4-yl]-(3-methoxyazetidin-1-yl)methanone;N-cyclopropyl-3-[4-[(2,5-difluorophenyl)-fluoromethyl]piperidin-1-yl]-7-methylpyrido[3,4-b]pyrazin-2-amine
SMILESCOC1CN(C(=O)C2CCN(c3nc4cnccc4nc3NC3CC3)CC2)C1.Cc1cc2nc(NC3CC3)c(N3CCC(C(F)c4cc(F)ccc4F)CC3)nc2cn1
InChIInChI=1S/C23H24F3N5.C20H26N6O2/c1-13-10-19-20(12-27-13)30-23(22(29-19)28-16-3-4-16)31-8-6-14(7-9-31)21(26)17-11-15(24)2-5-18(17)25;1-28-15-11-26(12-15)20(27)13-5-8-25(9-6-13)19-18(22-14-2-3-14)23-16-4-7-21-10-17(16)24-19/h2,5,10-12,14,16,21H,3-4,6-9H2,1H3,(H,28,29);4,7,10,13-15H,2-3,5-6,8-9,11-12H2,1H3,(H,22,23)
InChIKeyLIRDQRQZDXWXAZ-UHFFFAOYSA-N
XLogP6.79
TPSA137.42 Ų
H-Bond Donors2
H-Bond Acceptors12
Rotatable Bonds10
Heavy Atoms59
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500809.94
LogP ≤ 56.79
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1012

Analyze [1-[2-(cyclopropylamino)pyrido[3,4-b]pyrazin-3-yl]piperidin-4-yl]-(3-methoxyazetidin-1-yl)methanone;N-cyclopropyl-3-[4-[(2,5-difluorophenyl)-fluoromethyl]piperidin-1-yl]-7-methylpyrido[3,4-b]pyrazin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [1-[2-(cyclopropylamino)pyrido[3,4-b]pyrazin-3-yl]piperidin-4-yl]-(3-methoxyazetidin-1-yl)methanone;N-cyclopropyl-3-[4-[(2,5-difluorophenyl)-fluoromethyl]piperidin-1-yl]-7-methylpyrido[3,4-b]pyrazin-2-amine?
The IUPAC name of [1-[2-(cyclopropylamino)pyrido[3,4-b]pyrazin-3-yl]piperidin-4-yl]-(3-methoxyazetidin-1-yl)methanone;N-cyclopropyl-3-[4-[(2,5-difluorophenyl)-fluoromethyl]piperidin-1-yl]-7-methylpyrido[3,4-b]pyrazin-2-amine (CID 118308605) is [1-[2-(cyclopropylamino)pyrido[3,4-b]pyrazin-3-yl]piperidin-4-yl]-(3-methoxyazetidin-1-yl)methanone;N-cyclopropyl-3-[4-[(2,5-difluorophenyl)-fluoromethyl]piperidin-1-yl]-7-methylpyrido[3,4-b]pyrazin-2-amine.
What is the SMILES notation for [1-[2-(cyclopropylamino)pyrido[3,4-b]pyrazin-3-yl]piperidin-4-yl]-(3-methoxyazetidin-1-yl)methanone;N-cyclopropyl-3-[4-[(2,5-difluorophenyl)-fluoromethyl]piperidin-1-yl]-7-methylpyrido[3,4-b]pyrazin-2-amine?
The canonical SMILES for [1-[2-(cyclopropylamino)pyrido[3,4-b]pyrazin-3-yl]piperidin-4-yl]-(3-methoxyazetidin-1-yl)methanone;N-cyclopropyl-3-[4-[(2,5-difluorophenyl)-fluoromethyl]piperidin-1-yl]-7-methylpyrido[3,4-b]pyrazin-2-amine is COC1CN(C(=O)C2CCN(c3nc4cnccc4nc3NC3CC3)CC2)C1.Cc1cc2nc(NC3CC3)c(N3CCC(C(F)c4cc(F)ccc4F)CC3)nc2cn1.
What is the InChIKey of [1-[2-(cyclopropylamino)pyrido[3,4-b]pyrazin-3-yl]piperidin-4-yl]-(3-methoxyazetidin-1-yl)methanone;N-cyclopropyl-3-[4-[(2,5-difluorophenyl)-fluoromethyl]piperidin-1-yl]-7-methylpyrido[3,4-b]pyrazin-2-amine?
The InChIKey is LIRDQRQZDXWXAZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H24F3N5.C20H26N6O2/c1-13-10-19-20(12-27-13)30-23(22(29-19)28-16-3-4-16)31-8-6-14(7-9-31)21(26)17-11-15(24)2-5-18(17)25;1-28-15-11-26(12-15)20(27)13-5-8-25(9-6-13)19-18(22-14-2-3-14)23-16-4-7-21-10-17(16)24-19/h2,5,10-12,14,16,21H,3-4,6-9H2,1H3,(H,28,29);4,7,10,13-15H,2-3,5-6,8-9,11-12H2,1H3,(H,22,23).
What are the key properties of [1-[2-(cyclopropylamino)pyrido[3,4-b]pyrazin-3-yl]piperidin-4-yl]-(3-methoxyazetidin-1-yl)methanone;N-cyclopropyl-3-[4-[(2,5-difluorophenyl)-fluoromethyl]piperidin-1-yl]-7-methylpyrido[3,4-b]pyrazin-2-amine?
[1-[2-(cyclopropylamino)pyrido[3,4-b]pyrazin-3-yl]piperidin-4-yl]-(3-methoxyazetidin-1-yl)methanone;N-cyclopropyl-3-[4-[(2,5-difluorophenyl)-fluoromethyl]piperidin-1-yl]-7-methylpyrido[3,4-b]pyrazin-2-amine has a molecular weight of 809.94 g/mol, XLogP of 6.79, 10 rotatable bonds, 2 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for [1-[2-(cyclopropylamino)pyrido[3,4-b]pyrazin-3-yl]piperidin-4-yl]-(3-methoxyazetidin-1-yl)methanone;N-cyclopropyl-3-[4-[(2,5-difluorophenyl)-fluoromethyl]piperidin-1-yl]-7-methylpyrido[3,4-b]pyrazin-2-amine is sourced from PubChem (CID 118308605), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).